Apexigen Inc. (APGN) NASDAQ
$0.39 - (-)
Market Cap: -
As of 08/22/23 12:00 AM EDT. Market closed.
Apexigen Inc. (APGN)
NASDAQ
$0.39
- (-)
Market Cap: -
As of 08/22/23 12:00 AM EDT. Market closed.
Add to Portfolio
apexigen is a clinical-stage biopharmaceutical company discovering and developing innovative immuno-oncology therapeutics generated by apximab™, the company’s proprietary antibody drug discovery platform. its lead immuno-oncology drug candidate, apx005m, is a potent immune-activating antibody against cd40 currently in phase 2 clinical ... read more
apexigen is a clinical-stage biopharmaceutical company discovering and developing innovative immuno-oncology therapeutics generated by apximab™, the company’s proprietary antibody drug discovery platform. its lead immuno-oncology drug candidate, apx005m, is a potent immune-activating antibody against cd40 currently in phase 2 clinical development. read less
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
PRICE CHART FOR APEXIGEN INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.38
Previous Close
$0.39
Days Range
$0.36 - $0.40
52 week range
- - -
Volume
95,726
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
24,861,926
Open
$0.38
Previous Close
$0.39
Days Range
$0.36 - $0.40
52 week range
- - -
Volume
95,726
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
24,861,926
FINANCIAL STATEMENTS FOR APEXIGEN INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR APEXIGEN INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Wong Amy | SVP, Finance and Operations | Aug 23, 2023 | Option Exercise | $0.39 | 15,561 | 5,993 | 66,565 | Aug 25, 2023, 07:20 PM |
| Sarena Francis Willard | President and COO | Aug 23, 2023 | Option Exercise | $0.39 | 31,123 | 11,985 | 124,296 | Aug 25, 2023, 07:17 PM |
| Duke William E. | Chief Financial Officer | Aug 23, 2023 | Option Exercise | $0.39 | 26,416 | 10,173 | 128,001 | Aug 25, 2023, 06:42 PM |
| Yang Xiaodong | Chief Executive Officer | Aug 23, 2023 | Option Exercise | $0.39 | 69,161 | 26,634 | 863,729 | Aug 25, 2023, 06:37 PM |
| Yang Xiaodong | Chief Executive Officer | Jun 15, 2023 | Option Exercise | $0.49 | 7,001 | 3,438 | 532,890 | Jun 23, 2023, 06:01 PM |
| Wong Amy | SVP, Finance and Operations | Jun 15, 2023 | Option Exercise | $0.49 | 2,777 | 1,364 | 82,126 | Jun 23, 2023, 05:57 PM |
| Sarena Francis Willard | President and COO | Jun 15, 2023 | Option Exercise | $0.49 | 6,917 | 3,397 | 155,419 | Jun 23, 2023, 05:54 PM |
| Hsu Frank J. | Chief Medical Officer | Jun 15, 2023 | Option Exercise | $0.49 | 4,323 | 2,123 | 16,354 | Jun 23, 2023, 05:51 PM |
| Duke William E. | Chief Financial Officer | Jun 15, 2023 | Option Exercise | $0.49 | 4,504 | 2,212 | 154,417 | Jun 23, 2023, 05:49 PM |
| Wong Amy | SVP, Finance and Operations | May 23, 2023 | Option Exercise | $0.40 | 12,234 | 4,894 | 84,903 | May 25, 2023, 04:25 PM |
| Duke William E. | Chief Financial Officer | May 23, 2023 | Option Exercise | $0.40 | 17,261 | 6,904 | 158,921 | May 25, 2023, 04:21 PM |
| Sarena Francis Willard | President and COO | May 23, 2023 | Option Exercise | $0.40 | 20,748 | 8,299 | 162,336 | May 25, 2023, 04:18 PM |
| Wong Amy | SVP, Finance and Operations | Dec 15, 2022 | Option Exercise | $1.06 | 2,851 | 3,022 | 13,637 | Dec 19, 2022, 05:57 PM |
| Sarena Francis Willard | Chief Operating Officer | Dec 15, 2022 | Option Exercise | $1.06 | 6,916 | 7,331 | 33,084 | Dec 19, 2022, 05:49 PM |
| Hsu Frank J. | Chief Medical Officer | Dec 15, 2022 | Option Exercise | $1.06 | 4,323 | 4,582 | 20,677 | Dec 19, 2022, 05:41 PM |
| Duke William E. | Chief Financial Officer | Dec 15, 2022 | Option Exercise | $1.06 | 4,503 | 4,773 | 26,182 | Dec 19, 2022, 05:09 PM |
| Yang Xiaodong | Chief Executive Officer | Dec 15, 2022 | Option Exercise | $1.06 | 7,001 | 7,421 | 531,391 | Dec 19, 2022, 05:00 PM |
| GLAZER CAPITAL, LLC | 10% Owner | Feb 11, 2021 | Sale | $11.31 | 400,000 | 4,524,000 | 225,000 | Feb 16, 2021, 04:46 PM |
| Brookline Capital Holdings LLC | 10% Owner | Feb 02, 2021 | Buy | $10.00 | 247,000 | 2,470,000 | 1,627,000 | Feb 04, 2021, 03:00 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Wong Amy | SVP, Finance and Operations | 08/23/2023 | 5,993 |
| Sarena Francis Willard | President and COO | 08/23/2023 | 11,985 |
| Duke William E. | Chief Financial Officer | 08/23/2023 | 10,173 |
| Yang Xiaodong | Chief Executive Officer | 08/23/2023 | 26,634 |
| Yang Xiaodong | Chief Executive Officer | 06/15/2023 | 3,438 |
| Wong Amy | SVP, Finance and Operations | 06/15/2023 | 1,364 |
| Sarena Francis Willard | President and COO | 06/15/2023 | 3,397 |
| Hsu Frank J. | Chief Medical Officer | 06/15/2023 | 2,123 |
| Duke William E. | Chief Financial Officer | 06/15/2023 | 2,212 |
| Wong Amy | SVP, Finance and Operations | 05/23/2023 | 4,894 |
| Duke William E. | Chief Financial Officer | 05/23/2023 | 6,904 |
| Sarena Francis Willard | President and COO | 05/23/2023 | 8,299 |
| Wong Amy | SVP, Finance and Operations | 12/15/2022 | 3,022 |
| Sarena Francis Willard | Chief Operating Officer | 12/15/2022 | 7,331 |
| Hsu Frank J. | Chief Medical Officer | 12/15/2022 | 4,582 |
| Duke William E. | Chief Financial Officer | 12/15/2022 | 4,773 |
| Yang Xiaodong | Chief Executive Officer | 12/15/2022 | 7,421 |
| GLAZER CAPITAL, LLC | 10% Owner | 02/11/2021 | 4,524,000 |
| Brookline Capital Holdings LLC | 10% Owner | 02/02/2021 | 2,470,000 |
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR APEXIGEN INC
STOCK BUYBACKS FOR APEXIGEN INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2022
7.54%
1Q
09/30/2022
17.93%
2Q
06/30/2022
-23.20%
3Q
03/31/2022
33.58%
4Q
12/31/2021
33.82%
5Q
09/30/2021
33.90%
6Q
06/30/2021
-21.85%
7Q
03/31/2021
-21.19%
8Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR APEXIGEN INC
LOADING...